Published in Int J Oncol on April 01, 1998
Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia. Evid Based Complement Alternat Med (2007) 1.26
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer (2006) 1.18
Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol. Free Radic Biol Med (2008) 1.10
Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture. Angiogenesis (2010) 1.07
trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr (2007) 1.05
Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells. PLoS One (2013) 1.01
Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells. Invest New Drugs (2005) 0.97
Pterostilbene simultaneously induces apoptosis, cell cycle arrest and cyto-protective autophagy in breast cancer cells. Am J Transl Res (2012) 0.96
Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition. Invest New Drugs (2004) 0.95
Pterostilbene simultaneously induced G0/G1-phase arrest and MAPK-mediated mitochondrial-derived apoptosis in human acute myeloid leukemia cell lines. PLoS One (2014) 0.95
Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines. Br J Cancer (2003) 0.92
Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B. FASEB J (2008) 0.91
Inhibition of citrinin-induced apoptotic biochemical signaling in human hepatoma G2 cells by resveratrol. Int J Mol Sci (2009) 0.89
Methoxylation enhances stilbene bioactivity in Caenorhabditis elegans. BMC Pharmacol (2008) 0.87
Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer. Nutr Cancer (2012) 0.85
Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule. Int J Nanomedicine (2015) 0.85
Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells. Br J Cancer (2004) 0.83
Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells. Growth Factors (2006) 0.80
Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells. Drug Des Devel Ther (2015) 0.79
Inhibition of mammalian DNA polymerases by resveratrol: mechanism and structural determinants. Biochem J (2005) 0.79
Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line. Oncol Lett (2014) 0.79
Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions. Oncotarget (2015) 0.77
Piceatannol suppresses the metastatic potential of MCF10A human breast epithelial cells harboring mutated H-ras by inhibiting MMP-2 expression. Int J Mol Med (2013) 0.76
Resveratrol protects against 2-bromopropane-induced apoptosis and disruption of embryonic development in blastocysts. Int J Mol Sci (2011) 0.76
Comparison of cytotoxicity of various concentrations origanum extract solution with 2% chlorhexidine gluconate and 5.25% sodium hypochlorite. Eur J Dent (2015) 0.76
PKC activation by resveratrol derivatives with unsaturated aliphatic chain. PLoS One (2012) 0.75
Isolation and Chemical Structural Characterisation of a Compound with Antioxidant Activity from the Roots of Senna italica. Evid Based Complement Alternat Med (2013) 0.75
Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA (1995) 11.90
Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res (1990) 9.85
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry (1999) 4.57
Adult health status of women with histories of childhood abuse and neglect. Am J Med (1999) 3.43
Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat (1982) 2.98
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood (2001) 2.73
Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Public Health (1994) 2.70
Comparative study of human and rat mammary tumorigenesis. Lab Invest (1990) 2.58
A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med (1993) 2.41
Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat (1999) 2.30
Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints. Arch Intern Med (1992) 2.27
The association between chronic pelvic pain, psychiatric diagnoses, and childhood sexual abuse. Obstet Gynecol (1988) 2.20
Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry (1990) 2.13
A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Arch Gen Psychiatry (2001) 2.08
Frustrating patients: physician and patient perspectives among distressed high users of medical services. J Gen Intern Med (1991) 2.08
Somatization: a spectrum of severity. Am J Psychiatry (1991) 2.03
A randomized trial of psychiatric consultation with distressed high utilizers. Gen Hosp Psychiatry (1992) 2.00
Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia (1998) 1.97
Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect (1996) 1.94
Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry (1999) 1.88
Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog (1991) 1.87
Biological and molecular bases of mammary carcinogenesis. Lab Invest (1987) 1.79
Psychiatric and otologic diagnoses in patients complaining of dizziness. Arch Intern Med (1993) 1.75
Burden: a review of measures used among caregivers of individuals with dementia. Gerontologist (1991) 1.72
Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst (1978) 1.71
Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev (1994) 1.68
Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. Genomics (1997) 1.68
Relationship of chronic pelvic pain to psychiatric diagnoses and childhood sexual abuse. Am J Psychiatry (1988) 1.65
DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J Natl Cancer Inst (1978) 1.60
IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity (2001) 1.56
Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res (1980) 1.55
Influence of age and parity on the development of the human breast. Breast Cancer Res Treat (1992) 1.54
Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol (1980) 1.54
Medical school pressures and their relationship to anxiety. J Nerv Ment Dis (1984) 1.53
Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr (2000) 1.53
Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res (1990) 1.53
Validity and responsiveness of the Minimum Data Set. J Am Geriatr Soc (1999) 1.53
Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J (2002) 1.51
Chronic neurologic sequelae to cholinesterase inhibition among agricultural pesticide applicators. Arch Environ Health (1996) 1.51
Subsyndromal ("mixed") anxiety--depression in primary care. J Gen Intern Med (1994) 1.50
Psychiatric diagnoses and sexual victimization in women with chronic pelvic pain. Psychosomatics (1996) 1.48
Cellular basis of breast cancer susceptibility. Oncol Res (1999) 1.45
Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia (2000) 1.45
The screen for caregiver burden. Gerontologist (1991) 1.44
The Cooperative Breast Cancer Tissue Resource: archival tissue for the investigation of tumor markers. Clin Cancer Res (2001) 1.43
Infectious mononucleosis: psychological symptoms during acute and subacute phases of illness. Gen Hosp Psychiatry (1999) 1.41
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis (2000) 1.38
Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol (1979) 1.37
The 13q- syndrome: the molecular definition of a critical deletion region in band 13q32. Am J Hum Genet (1995) 1.36
Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol (2004) 1.33
Cancer risk related to mammary gland structure and development. Microsc Res Tech (2001) 1.30
Predictors of burden in spouse caregivers of individuals with Alzheimer's disease. Psychol Aging (1991) 1.29
Perceived stress in medical school: resistors, persistors, adaptors and maladaptors. Soc Sci Med (1989) 1.27
Can depression treatment in primary care reduce disability? A stepped care approach. Arch Fam Med (2001) 1.26
A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull (2001) 1.24
Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry (1993) 1.23
Experimentally induced mammary tumors in rats. Breast Cancer Res Treat (1996) 1.22
Mental illness, functional impairment, and patient preferences for collaborative care in an uninsured, primary care population. J Fam Pract (2001) 1.20
Somatic complaints among pregnant women cared for in obstetrics: normal pregnancy or depressive and anxiety symptom amplification revisited? Gen Hosp Psychiatry (2001) 1.19
S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int J Oncol (2000) 1.19
Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosom Med (1998) 1.19
A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am (1999) 1.17
Estrogen and xenoestrogens in breast cancer. Toxicol Pathol (2009) 1.17
Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis (1993) 1.16
Medical student distress. A longitudinal study. J Nerv Ment Dis (1989) 1.13
Raw versus relative scores in the assessment of coping strategies. J Behav Med (1987) 1.13
Racial differences in breast cancer patients. J Natl Cancer Inst (1985) 1.12
Chronic tinnitus: association with psychiatric diagnoses. J Psychosom Res (1987) 1.12
Chest pain: relationship of psychiatric illness to coronary arteriographic results. Am J Med (1988) 1.11
Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am J Med (1995) 1.11
Appraised changeability of a stressor as a modifier of the relationship between coping and depression: a test of the hypothesis of fit. J Pers Soc Psychol (1990) 1.10
The clinical utility of the dementia rating scale for assessing Alzheimer patients. J Chronic Dis (1984) 1.09
Estrogen-dependent trypsin-like activity in the rat uterus. Localization of activity in the 12,000g pellet and nucleus. Arch Biochem Biophys (1976) 1.09
Lipid and lipoprotein profiles, cardiovascular fitness, body composition, and diet during and after resistance, aerobic and combination training in young women. Eur J Appl Physiol (2000) 1.08
The Ways of Coping Checklist: Revision and Psychometric Properties. Multivariate Behav Res (1985) 1.08
Influence of age and gland topography on cell kinetics of normal human breast tissue. J Natl Cancer Inst (1987) 1.05
Predictors of recurrence and survival of patients with breast cancer. Am J Clin Pathol (1987) 1.04
Differentiation and breast cancer. Medicina (B Aires) (1997) 1.04
Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. Am J Pathol (1983) 1.04
Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst (1990) 1.03
Disabling tinnitus. Association with affective disorder. Gen Hosp Psychiatry (1988) 1.03
Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2001) 1.03
Increased pH-lowering ability of Streptococcus mutans cell masses associated with extracellular glucan-rich matrix material and the mechanisms involved. J Dent Res (1989) 1.02
Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer (1990) 1.02
Predictors of outcome in a primary care depression trial. J Gen Intern Med (2000) 1.01
Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res (1988) 0.99
Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomarkers Prev (1994) 0.99
Reexpression of the original tumor pattern by a human breast carcinoma cell line (MCF-7) in sponge culture. J Natl Cancer Inst (1976) 0.98
Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. Int J Oncol (1998) 0.98